H3B-5942
目录号: PL02068 纯度: ≥98%
CAS No. :2052128-15-9
商品编号 规格 价格 会员价 是否有货 数量
PL02068-1mg 1mg ¥770.00 请登录
PL02068-5mg 5mg ¥3377.50 请登录
PL02068-10mg 10mg ¥5967.50 请登录
PL02068-25mg 25mg ¥9327.50 请登录
PL02068-50mg 50mg ¥15912.00 请登录
PL02068-100mg 100mg 询价 询价
PL02068-200mg 200mg 询价 询价
PL02068-10mM*1mLinDMSO 10mM*1mLinDMSO ¥3323.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
H3B-5942
英文名称
H3B-5942
英文别名
s8746;(E)-4-[2-[4-[(E)-1-(1H-Indazol-5-yl)-2-phenylbut-1-enyl]phenoxy]ethylamino]-N,N-dimethylbut-2-enamid;H3B-5942
Cas No.
2052128-15-9
分子式
C31H34N4O2
分子量
494.63
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
H3B-5942 是一种选择性、不可逆、可口服的 estrogen receptor 共价拮抗剂,能够靶作用于 Cys530,使野生型和突变型 ERα 失活,Ki 值分别为 1 nM 和 0.41 nM。H3B-5942 能够减少 ERα 的目标基因 GREB1 的表达。H3B-5942 具有抗癌作用,对含有 ERαWT 或者突变型 ERα 的肿瘤细胞和动物具有抗肿瘤活性。
生物活性
H3B-5942 is a selective, irreversible and orally active estrogen receptor covalent antagonist, inactivates both wild-type and mutant ERα by targeting Cys530, with K i s of 1 nM and 0.41 nM, respectively. H3B-5942 reduces ERα target gene GREB1, shows potent antitumor activity both in multiple cell lines or animals bearing ERα or ERα mutations.
性状
Solid
IC50 & Target[1][2]
ERα 0.41 nM (Ki) ERα 1 nM (Ki)
体外研究(In Vitro)
H3B-5942 is a selective and irreversible estrogen receptor covalent antagonist, inactivates both wild-type and mutant ERα by targeting Cys530, with Kis of 1 nM and 0.41 nM, respectively.
H3B-5942 elevates ERα protein level distinct from SERMs/SERD, blocks ERα-dependent transcription in breast cancer cells. H3B-5942 (0.01-10 μM) reduces ERα target gene GREB1 in MCF7-ERα, various MCF7-ERαMUT lines, and the PDX-ERα/WT line.
H3B-5942 also decreases proliferation of MCF7-Parental, MCF7-LTED-ERα, and MCF7-LTED-ERα lines with GI50s of 0.5, 2, and 30 nM, respectively. H3B-5942 (10-25 nM) in combination with CDK4/6 inhibitors (≥25 pM) has synergic inhibitory effect on multiple cell lines bearing ERα or clinically frequent ERα mutations. has not independently confirmed the accuracy of these
体内研究(In Vivo)
H3B-5942 (1, 3, 10, or 30 mg/kg, p.o, q.d. for 17 days) dose-dependently inhibits tumor growth in MCF7 xenograft model in athymic female nude mice.
H3B-5942 (3, 10, 30, 100, and 200 mg/kg, p.o, q.d.) exhibits similar anti-tumor activity in the ERα ST941 model in athymic female nude mice. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Puyang X, et al. Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer. Cancer Discov. 2018 Sep;8(9):1176-1193.
溶解度数据
In Vitro: DMSO : 83.33 mg/mL (168.47 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2